Search Results

Your search for Joseph A. Sparano, MD, FACP, 2018–2019 Chair, ASCO Nominating Committee,Joseph A. Sparano, MD, FACP, 2018–2019 Chair, ASCO Nominating Committee matches 2 pages

Showing 1 - 2

By Joseph A. Sparano, MD, FACP, 2018–2019 Chair, ASCO Nominating Committee / November 25, 2018

Your Voice Matters: Vote in the ASCO Election by December 3

Each year, we call upon the ASCO members to place their votes to select our Society’s future leaders. This year, we are asking that you not only vote for the open leadership positions, but also for a proposed bylaw change. ASCO’s mission is more urgent than ever in today’s landscape of fast-moving ...

By The ASCO Post Staff / Thursday, December 17, 2015 10:48 AM

Bruce E. Johnson, MD, FASCO, Elected ASCO President for 2017–2018 Term

Bruce E. Johnson, MD, FASCO, has been elected President of ASCO for the term beginning in June 2017. He will take office as President-Elect during the ASCO Annual Meeting in Chicago in June 2016. Additionally, four new members were elected to the ASCO Board of Directors, as well as three new...

Dec

Today In Oncology

Search Results

Your search for Joseph A. Sparano, MD, FACP, 2018–2019 Chair, ASCO Nominating Committee,Joseph A. Sparano, MD, FACP, 2018–2019 Chair, ASCO Nominating Committee matches 2 pages

Your Voice Matters: Vote in the ASCO Election by December 3

Bruce E. Johnson, MD, FASCO, Elected ASCO President for 2017–2018 Term

CAR T-Cell Therapy for Relapsed/Refractory Mantle Cell Lymphoma: ZUMA-2

Primary Analysis of ZUMA-2: Treatment of BTK Inhibitor–Naive Relapsed/Refractory Mantle Cell Lymphoma

Pirtobrutinib May Improve Survival Outcomes in Pretreated Patients With CLL or SLL

UICC ICCP Landmark Review of National Cancer Strategies Illuminates Progress Persistent Challenges

Researchers May Have Uncovered Protein That Helps Cancer Cells Dodge CAR T Cell Therapy